Sronyx
Product Images NDC 53002-1539

5 FDA label images from Rpk Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sronyx (NDC 53002-1539). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530021539)

Label Image (Lbl530021539)
SRONYX 0.1/0.02MG tablets in a 28-day regimen blister pack container label by RPK Pharmaceuticals, Inc. The label instructs to take one tablet daily as directed. It includes a patient name field, directions, NDC number 53002-1539, lot number, expiration date, and placeholders for clinic and billing information.*
FDA Label Image

Chemical Structure (Sronyx 01)

Chemical Structure (Sronyx 01)
Chemical structure diagram showing the molecular structures of Levonorgestrel and Ethinyl Estradiol, the active ingredients in SRONYX by RPK Pharmaceuticals, Inc.*
FDA Label Image

Figure 1 (Sronyx 02)

Figure 1 (Sronyx 02)
Two line graphs showing mean serum concentrations of levonorgestrel and ethinyl estradiol over time (in hours) after a single dose and on day 21 of cycles 1 and 3. The top graph depicts levonorgestrel concentrations (pg/mL) and the bottom graph depicts ethinyl estradiol concentrations (pg/mL), both plotted against time up to 30 hours.*
FDA Label Image

Image (Sronyx 03)

Image (Sronyx 03)
A monthly self-breast exam tracking chart for Sronyx tablets showing a 28-day cycle arranged in four rows and seven columns for each day of the week. Each circle represents a pill taken daily, with arrows indicating the sequence from Sunday to Saturday across four weeks. Week 4 tablets are noted as inactive, containing levonorgestrel and ethinyl estradiol 0.1 mg/0.02 mg. The chart guides users to start and follow the arrows for proper usage.*
FDA Label Image

Image (Sronyx 04)

Image (Sronyx 04)
SRONYX oral contraceptive monthly pill pack label showing a 4-week grid of circular tablet positions arranged by day and week, indicating active and inactive tablets. The label includes dosing instructions with arrows and specifies the active ingredients levonorgestrel and ethinyl estradiol (0.1 mg/0.02 mg). The labeler is RPK Pharmaceuticals, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.